<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37485095</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae.</ArticleTitle><Pagination><StartPage>e40717</StartPage><MedlinePgn>e40717</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.40717</ELocationID><Abstract><AbstractText>Background Multisystem involvement in coronavirus disease 2019 (COVID-19) is known since the beginning of the pandemic, and post-COVID-19 sequelae have often been reported. The term 'long Covid' encompasses these signs and symptoms. The aim of our study was to study different after-effects which patients endured within 12 months after recovery from acute COVID-19 and to study the various risk predictors. Methods This was a longitudinal observational study of a cohort of 146 patients who recovered from COVID-19 illness. Patients were enrolled during the first four weeks of the onset of their illness, and a monthly follow-up assessment was done for six months that included a detailed history of persistent or new symptoms, new illnesses diagnosed, and complete biochemical, pulmonary, cardiac, neurological and psychiatric evaluation, both objective and subjective. A final follow-up was also done at the end of one year of enrolment. Based on the patient's self-reported history and our multi-system assessment, recorded sequelae were classified according to the involved organ system. These were correlated with possible risk predictors and statistically significant associations were established. Results One hundred and twenty subjects out of 146 total subjects qualified for final analysis. Pulmonary sequelae (48/120; 40%) were the most followed by psychiatric (30/120; 25%), neurological (26/120; 21.7%), and opportunistic infections (7/120; 5.8%). A total of 39/120 (32.1%) cases complained of prolonged dyspnoea. Six out of 120 i.e. 5% of study participants had new-onset diabetes. Twenty-six out of 120 (21.7%) had radiological signs of pulmonary fibrosis. Patients with co-morbidities, older age, higher body mass index, and patients with severe disease were found to be at higher risk of developing these sequelae. Poor nutrition, female gender, and hospitalization were predictors of psychiatric sequelae. Diabetes and liberal steroid use during COVID-19 management were predictors of opportunistic fungal infections. Conclusion This study evaluated post-COVID-19 sequalae in-depth both objectively and subjectively. Some specific predictors for specific sequelae were confirmed on statistical correlation. Long-term follow-up of high-risk persons is therefore recommended after the cure of COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Gujral et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gujral</LastName><ForeName>Harshmeet Singh</ForeName><Initials>HS</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Respiratory Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahasrabudhe</LastName><ForeName>Tushar R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nirmala</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Aster Medcity, Bangalore, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid</Keyword><Keyword MajorTopicYN="N">multisystem</Keyword><Keyword MajorTopicYN="N">pulmonary fibrosis</Keyword><Keyword MajorTopicYN="N">risk predictors</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>4</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37485095</ArticleId><ArticleId IdType="pmc">PMC10359831</ArticleId><ArticleId IdType="doi">10.7759/cureus.40717</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus disease (COVID-19) weekly epidemiological updates and monthly operational updates.  [
Jun;
2023 
]. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</Citation></Reference><Reference><Citation>Modeling the onset of symptoms of COVID-19. Larsen JR, Martin MR, Martin JD, Kuhn P, Hicks JB. Front Public Health. 2020;8:473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438535</ArticleId><ArticleId IdType="pubmed">32903584</ArticleId></ArticleIdList></Reference><Reference><Citation>6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent symptoms in patients after acute COVID-19. Carf&#xec; A, Bernabei R, Landi F. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-acute COVID-19 syndrome. Nalbandian A, Sehgal K, Gupta A, et al. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline (NG188)  [
Jun;
2023 
]. 2020. https://www.nice.org.uk/guidance/ng188 https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical guidance and management of adult COVID-19.  [
Mar;
2023 
]. 2023. https://www.icmr.gov.in/pdf/covid/techdoc/COVID_Clinical_Management_19032023.pdf https://www.icmr.gov.in/pdf/covid/techdoc/COVID_Clinical_Management_19032023.pdf</Citation></Reference><Reference><Citation>Sequelae in adults at 6 months after COVID-19 infection. Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. JAMA Netw Open. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 syndrome: nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in Nord Franche-Comt&#xe9; Hospital, France. Zayet S, Zahra H, Royer PY, et al. Microorganisms. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. Datta SD, Talwar A, Lee JT. JAMA. 2020;324:2251&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Comorbidity and its impact on patients with COVID-19. Sanyaolu A, Okorie C, Marinkovic A, et al. SN Compr Clin Med. 2020;2:1069&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. Halpin SJ, McIvor C, Whyatt G, et al. J Med Virol. 2021;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Follow-up CT patterns of residual lung abnormalities in severe COVID-19 pneumonia survivors: a multicenter retrospective study. Besutti G, Monelli F, Schir&#xf2; S, et al. Tomography. 2022;8:1184&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9149852</ArticleId><ArticleId IdType="pubmed">35645383</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Thye AY, Law JW, Tan LT, et al. Biology (Basel) 2022;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Differences in the course of depression and anxiety after COVID-19 infection between recovered patients with and without a psychiatric history: a cross-sectional study. Hazumi M, Usuda K, Okazaki E, Kataoka M, Nishi D. Int J Environ Res Public Health. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9517442</ArticleId><ArticleId IdType="pubmed">36141588</ArticleId></ArticleIdList></Reference><Reference><Citation>An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. Eaton NR, Keyes KM, Krueger RF, et al. J Abnorm Psychol. 2012;121:282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402021</ArticleId><ArticleId IdType="pubmed">21842958</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. (&#x200e;2002. Gender and mental health.  [
Jun;
2023 
]. 2002. https://apps.who.int/iris/handle/10665/68884 https://apps.who.int/iris/handle/10665/68884</Citation></Reference><Reference><Citation>Assessment of nutritional status and risk of malnutrition using adapted standard tools in patients with mental illness and in need of intensive psychiatric treatment. Risch L, Hotzy F, Vetter S, Hiller S, Wallimann K, Seifritz E, M&#xf6;tteli S. Int J Environ Res Public Health. 2022;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9819142</ArticleId><ArticleId IdType="pubmed">36612431</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatric complications of treatment with corticosteroids: review with case report. Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatry Clin Neurosci. 2011;65:549&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">22003987</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Montefusco L, Ben Nasr M, D'Addio F, et al. Nat Metab. 2021;3:774&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellular death, reactive oxygen species (ROS) and diabetic complications. Volpe CM, Villar-Delfino PH, Dos Anjos PM, Nogueira-Machado JA. Cell Death Dis. 2018;9:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833737</ArticleId><ArticleId IdType="pubmed">29371661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatal mucormycosis post COVID-19 infection in uncontrolled diabetes with misuse of glucocorticoids and antibiotics. Hamed H, Madia R, Ladadweh H, Falana H, AbuKhalil AD. Infect Drug Resist. 2022;15:1121&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939863</ArticleId><ArticleId IdType="pubmed">35330787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>